Paris, France

Jean-Philippe Letallec

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 7.2

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2009-2023

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Jean-Philippe Letallec

Introduction: Jean-Philippe Letallec, an accomplished inventor based in Paris, France, has made significant strides in the field of pharmaceutical innovations. With a total of six patents to his name, his research focuses on the development of novel compounds that hold promise for treating serious medical conditions, particularly cancer.

Latest Patents: Letallec's latest patent contributions include two key innovations: the derivatives of 2,3-dihydro-1H-imidazo{1,2-a}pyrimidin-5-one and 1,2,3,4-tetrahydropyrimido{1,2-a}pyrimidin-6-one, which incorporate a substituted morpholine. These patents detail the preparation and pharmaceutical use of these compounds, emphasizing their potential as anticancer medicaments. The products are characterized by complex chemical structures that allow for a variety of substitutions and configurations, showcasing Letallec's expertise in medicinal chemistry.

Career Highlights: Throughout his career, Jean-Philippe Letallec has been associated with prominent pharmaceutical companies, including Sanofi and Aventis Pharma. His work within these organizations has contributed to groundbreaking advancements in drug development and therapeutic applications, enhancing his position as a leading figure in pharmaceutical innovation.

Collaborations: Letallec has collaborated with notable colleagues such as Baptiste Ronan and Eric Bacque. Their teamwork reflects a commitment to pushing the boundaries of medical research and creating effective solutions for unmet medical needs.

Conclusion: Jean-Philippe Letallec stands out as an influential inventor whose patents reflect a deep understanding of chemistry and a dedication to improving health outcomes. His ongoing contributions to the pharmaceutical industry continue to inspire future innovations and pave the way for potential therapies to combat cancer and other diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…